These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25623266)

  • 1. Autoimmunity and antibody affinity maturation are modulated by genetic variants on mouse chromosome 12.
    Collin R; Dugas V; Chabot-Roy G; Salem D; Zahn A; Di Noia JM; Rauch J; Lesage S
    J Autoimmun; 2015 Apr; 58():90-9. PubMed ID: 25623266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TCR transgenic mice reveal the impact of type 1 diabetes loci on early and late disease checkpoints.
    Hillhouse EE; Liston A; Collin R; Desautels E; Goodnow CC; Lesage S
    Immunol Cell Biol; 2016 Aug; 94(7):709-13. PubMed ID: 27046082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mouse idd2 locus is linked to the proportion of immunoregulatory double-negative T cells, a trait associated with autoimmune diabetes resistance.
    Collin R; Dugas V; Pelletier AN; Chabot-Roy G; Lesage S
    J Immunol; 2014 Oct; 193(7):3503-12. PubMed ID: 25165153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of genetic epistasis in autoimmune diabetes susceptibility revealed by mouse congenic sublines.
    Collin R; Dugas V; Pelletier AN; Chabot-Roy G; Lesage S
    Immunogenetics; 2021 Aug; 73(4):307-319. PubMed ID: 33755757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic control of anti-Sm autoantibody production in NOD congenic mice narrowed to the Idd9.3 region.
    Irie J; Wu Y; Sass DA; Ridgway WM
    Immunogenetics; 2006 Feb; 58(1):9-14. PubMed ID: 16425035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissecting genetic control of autoimmunity in NOD congenic mice.
    Ridgway WM
    Immunol Res; 2006; 36(1-3):189-95. PubMed ID: 17337779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced responsiveness to T-cell help causes loss of B-lymphocyte tolerance to a β-cell neo-self-antigen in type 1 diabetes prone NOD mice.
    Cox SL; Stolp J; Hallahan NL; Counotte J; Zhang W; Serreze DV; Basten A; Silveira PA
    Eur J Immunol; 2010 Dec; 40(12):3413-25. PubMed ID: 21108464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic control of autoimmunity: protection from diabetes, but spontaneous autoimmune biliary disease in a nonobese diabetic congenic strain.
    Koarada S; Wu Y; Fertig N; Sass DA; Nalesnik M; Todd JA; Lyons PA; Fenyk-Melody J; Rainbow DB; Wicker LS; Peterson LB; Ridgway WM
    J Immunol; 2004 Aug; 173(4):2315-23. PubMed ID: 15294944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased autoimmune diabetes in pIgR-deficient NOD mice is due to a "Hitchhiking" interval that refines the genetic effect of Idd5.4.
    Simpfendorfer KR; Strugnell RA; Brodnicki TC; Wijburg OL
    PLoS One; 2015; 10(4):e0121979. PubMed ID: 25835383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The
    Lombard-Vadnais F; Collin R; Daudelin JF; Chabot-Roy G; Labrecque N; Lesage S
    J Immunol; 2022 Feb; 208(4):898-909. PubMed ID: 35039332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Centromeric interval of chromosome 4 derived from C57BL/6 mice accelerates type 1 diabetes in NOD.CD72b congenic mice.
    Hou R; Ohtsuji M; Ohtsuji N; Zhang L; Adachi T; Hirose S; Tsubata T
    Biochem Biophys Res Commun; 2009 Feb; 380(1):193-7. PubMed ID: 19167349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-producing intestinal K cells protect nonobese diabetic mice from autoimmune diabetes.
    Mojibian M; Lam AW; Fujita Y; Asadi A; Grassl GA; Dickie P; Tan R; Cheung AT; Kieffer TJ
    Gastroenterology; 2014 Jul; 147(1):162-171.e6. PubMed ID: 24662331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responses of NOD congenic mice to a glutamic acid decarboxylase-derived peptide.
    Chen SL; Whiteley PJ; Freed DC; Rothbard JB; Peterson LB; Wicker LS
    J Autoimmun; 1994 Oct; 7(5):635-41. PubMed ID: 7840855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibody patterns in diabetes-prone NOD mice and in standard C57BL/6 mice.
    Quintana FJ; Cohen IR
    J Autoimmun; 2001 Nov; 17(3):191-7. PubMed ID: 11712856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic control of autoimmune diabetes in the NOD mouse.
    Wicker LS; Todd JA; Peterson LB
    Annu Rev Immunol; 1995; 13():179-200. PubMed ID: 7612220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of autoimmunity by immunization with hapten-modified hen egg lysozyme in hen egg lysozyme-transgenic mice.
    Kang HK; Chung YJ; Park CU; Jang YS; Kim BS
    Immunology; 2006 Mar; 117(3):368-78. PubMed ID: 16476056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence on spontaneous tissue inflammation by the major histocompatibility complex region in the nonobese diabetic mouse.
    Lindqvist AK; Nakken B; Sundler M; Kjellén P; Jonsson R; Holmdahl R; Skarstein K
    Scand J Immunol; 2005 Feb; 61(2):119-27. PubMed ID: 15683448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmunity triggers in the NOD mouse: a role for natural auto-antibody reactivities in type 1 diabetes.
    Côrte-Real J; Duarte N; Tavares L; Penha-Gonçalves C
    Ann N Y Acad Sci; 2009 Sep; 1173():442-8. PubMed ID: 19758184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The preferential ability of B lymphocytes to act as diabetogenic APC in NOD mice depends on expression of self-antigen-specific immunoglobulin receptors.
    Silveira PA; Johnson E; Chapman HD; Bui T; Tisch RM; Serreze DV
    Eur J Immunol; 2002 Dec; 32(12):3657-66. PubMed ID: 12516557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of QTLs that modify peripheral neuropathy in NOD.H2b-Pdcd1-/- mice.
    Jiang F; Yoshida T; Nakaki F; Terawaki S; Chikuma S; Kato Y; Okazaki IM; Honjo T; Okazaki T
    Int Immunol; 2009 May; 21(5):499-509. PubMed ID: 19261693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.